The National Health Authority (NHA) has released a consultation paper on drug registry. Envisioned under the ambitious Ayushman Bharat Digital Mission (ABDM), the registry is intended to be a single, up-to-date, centralised repository of all the drugs across all systems of medicine which are approved and are available in the Indian market, noted a release by the Health Ministry on Friday.
The drug registry application is proposed to be designed using open-source technologies and will be interoperable. The consultation paper focuses only on the registry within the National Digital Health Ecosystem and offers the NHA’s current vision on the functionalities of the proposed registry, the process for its creation and potential benefits to various ecosystem stakeholders, the Ministry noted.
